Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Net Cash Flow: 2020-2025

Historic Net Cash Flow for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$50.9 million.

  • CureVac N.V's Net Cash Flow rose 51.72% to -$50.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $212.1 million, marking a year-over-year increase of 158.45%. This contributed to the annual value of $83.7 million for FY2024, which is 184.34% up from last year.
  • CureVac N.V's Net Cash Flow amounted to -$50.9 million in Q2 2025, which was down 11.92% from -$45.4 million recorded in Q1 2025.
  • CureVac N.V's 5-year Net Cash Flow high stood at $302.4 billion for Q4 2021, and its period low was -$348.0 billion during Q3 2021.
  • In the last 3 years, CureVac N.V's Net Cash Flow had a median value of -$69.6 million in 2023 and averaged -$10.6 million.
  • In the last 5 years, CureVac N.V's Net Cash Flow surged by 57,667.14% in 2021 and then tumbled by 84,113.08% in 2022.
  • Over the past 5 years, CureVac N.V's Net Cash Flow (Quarterly) stood at $302.4 billion in 2021, then tumbled by 100.01% to -$37.5 million in 2022, then crashed by 70.63% to -$63.9 million in 2023, then fell by 17.68% to -$75.2 million in 2024, then surged by 51.72% to -$50.9 million in 2025.
  • Its last three reported values are -$50.9 million in Q2 2025, -$45.4 million for Q1 2025, and -$75.2 million during Q4 2024.